Luciano Rossetti, M.D., has been appointed executive vice president and global head of R&D at Merck KGaA’s biopharmaceutical division, as of July 21st. Dr. Rossetti will be based in Billerica, MA.   Dr. Rossetti most recently served as senior vice president of Late Stage Development at Merck Sharp & Dohme, where he was responsible for all clinical development from Phase II – V across all therapeutic areas. He also played a key role in implementing the development strategy of severa...